Showing posts with label embryonic stem cell research. Show all posts
Showing posts with label embryonic stem cell research. Show all posts

Friday, August 22, 2014

Archbishop Aymond on the ALS ice bucket challenge: no embryonic stem cell support

On ice bucket challenge, New Orleans archbishop cautions Catholics about donations


 
Jessica Williams, NOLA.com | The Times-Picayune By Jessica Williams, NOLA.com | The Times-Picayune The Times-Picayune  
 
on August 21, 2014 







The Archdiocese of New Orleans has released its own guidance on whether Roman Catholics should participate in the "ice bucket challenge" and donate to ALS disease research. They may do so, Archbishop Gregory Aymond said, in a way that's "morally acceptable" -- by not donating money to organizations that fund embryonic stem cell research.
The challenge requires an individual to endure having a bucket of cold water dumped on the head, to donate to an ALS charity and to challenge another to do the same via video. Videos of participants being doused have gone viral over social media.
But a popular charity of choice, the ALS Association, has been accused of funding research that uses destroyed human embryos, which many Catholics liken to abortion. In Cincinnati, Catholic school principals have been asked not to encourage student donations to that group.
In a recent email to New Orleans archdiocese priests, parishes, offices and ministries, Aymond asks participants to contribute to "morally acceptable" research. "There has been quite a stir regarding the ALS Ice Bucket Challenge," he wrote. "The research is done with embryonic stem cells, which is against our Pro-Life stance."
But, some charities, such as former Saints player Steve Gleason's Team Gleason, funds research that doesn't use these stem cells, Aymond said. Team Gleason's executive director, Paul Varisco, confirmed that Thursday.
Employees at two local Catholic schools, St. Louis King of France in Metairie and Stuart Hall in New Orleans, selected Gleason's group when they participated in the challenge.
Aymond also noted that many Catholics suffer with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, which progressively affects nerve cells in the brain and spinal cord. He mentioned Gleason and the Rev. Ray Fitzgerald, former president of Jesuit High School. "Please join me in prayer for all those who suffer from this disease and for their families," he said.
Some of Team Gleason's chief initiatives have been raising money for assistive technology to help those diagnosed with ALS communicate and raising public awareness about the disease. The ALS Association is listed among more than 40 partners on Team Gleason's website.
Varisco said the partnership is not financial; rather, "it's one of support to each other." ALS holds an annual Walk to Defeat ALS, for example, and Team Gleason promotes it, he said.
"Our missions are in some ways alike, but they differ in some ways," he said.

Monday, October 8, 2012

Notice: not embryonic but ADULT stem cell research worthy of the Nobel Prize

Nobel Prize in medicine goes to British, Japanese stem-cell researchers

In this April, 2008 photo, Kyoto University Professor Shinya Yamanaka, left, and British researcher John Gurdon exchange greetings as they attend a symposium on induced pluripotent stem cell in Tokyo. Gurdon and Yamanaka of Japan won this year's Nobel Prize in physiology or medicine for discovering that mature, specialized cells of the body can be reprogrammed into stem cells -- a discovery that scientists hope to turn into new treatments. (Photo by AP Photo/Kyodo News)
 
The Associated Press By The Associated Press
on October 08, 2012
STOCKHOLM — British researcher John Gurdon and Shinya Yamanaka of Japan won this year's Nobel Prize in physiology or medicine on Monday for discovering that mature, specialized cells of the body can be reprogrammed into stem cells — a discovery that scientists hope to turn into new treatments.
Scientists want to harness that reprogramming to create replacement tissues for treating diseases like Parkinson's and diabetes, and for studying the roots of diseases in the laboratory.
The prize committee at Stockholm's Karolinska Institute said the discovery has "revolutionized our understanding of how cells and organisms develop."
Gurdon showed in 1962 — the year Yamanaka was born — that the DNA from specialized cells of frogs, like skin or intestinal cells, could be used to generate new tadpoles. That showed the DNA still had its ability to drive the formation of all cells of the body.
In 1997, the cloning of Dolly the sheep by other scientists showed that the same process Gurdon discovered in frogs would work in mammals.
More than 40 years after Gurdon's discovery, in 2006, Yamanaka showed that a surprisingly simple recipe could turn mature cells back into primitive cells, which in turn could be prodded into different kinds of mature cells.
Basically, the primitive cells were the equivalent of embryonic stem cells, which had been embroiled in controversy because to get human embryonic cells, human embryos had to be destroyed. Yamanaka's method provided a way to get such primitive cells without destroying embryos.
"The discoveries of Gurdon and Yamanaka have shown that specialized cells can turn back the developmental clock under certain circumstances," the committee said. "These discoveries have also provided new tools for scientists around the world and led to remarkable progress in many areas of medicine."
Just last week, Japanese scientists reported using Yamanaka's approach to turn skin cells from mice into eggs that produced baby mice.
Gurdon, 79, has served as a professor of cell biology at Cambridge University's Magdalene College and is currently at the Gurdon Institute in Cambridge, which he founded. Yamanaka, 50, worked at the Gladstone Institute in San Francisco and Nara Institute of Science and Technology in Japan. He is currently at Kyoto University and also affiliated with the Gladstone Institute. Yamanaka is the first Japanese scientist to win the Nobel medicine award since 1987.
"From now on, I'd like to make a contribution to society in a real sense. I feel a great sense of responsibility," Yamanaka said at a news conference in Japan. "I want to use our medical breakthrough for medical purposes."
Choosing Yamanaka as a Nobel winner just six years after his discovery was unusual. The Nobel committees typically reward research done more than a decade ago, to make sure it has stood the test of time.
In 2010, the Nobel Prize in physics went to two researchers whose discoveries were also published six years earlier. In 2006, two American scientists won the medicine prize eight years after their work was published.
Prize committee member Juleen Zierath said Gurdon and Yamanaka's discoveries, which also earned them a Lasker award for basic research in 2009, could hold "immense potential," including in developing treatments for Parkinson's disease and in making cells that produce insulin. However, she added that therapeutic implications are still far away.
The idea of reprograming cells has also been put to work in basic research on disease, through an approach sometimes called "disease in a dish."
The reprogramming allows scientists to create particular kinds of tissue they want to study, like lung tissue for studying cystic fibrosis, or brain tissue for Huntington's disease. By reprogramming cells from patients with a particular disease, they can create new tissue with the same genetic background, and study it in the lab. That can give new insights into the roots of the problem.
In addition, that approach allows them to screen drugs in the lab for possible new medicines.
Experts welcomed the announcement, praising the duo for their groundbreaking and influential discoveries in a field riddled with ethical debates.
"Everyone who works on developmental biology and on the understanding of disease mechanisms will applaud these excellent and clear choices for the Nobel prizes," said John Hardy, professor of Neuroscience at University College London. "Countless labs' work builds on the breakthroughs they have pioneered."
Goran Hansson, the secretary of the prize committee, said he had reached both winners by phone before the announcement. He said they were looking forward to coming to Stockholm to collect the 8 million kronor ($1.2 million) award on Dec. 10.
The medicine award was the first Nobel Prize to be announced this year. The physics award will be announced Tuesday, followed by chemistry on Wednesday, literature on Thursday and the Nobel Peace Prize on Friday.
The economics prize, which was not among the original awards, but was established by the Swedish central bank in 1968, will be announced on Oct. 15. All prizes will be handed out on Dec. 10, the anniversary of prize founder Alfred Nobel's death in 1896.
Last year's medicine award to Canadian-born Ralph Steinman, American Bruce Beutler and French scientist Jules Hoffmann briefly created some confusion when it was announced that Steinman had died a few days earlier. Posthumous prizes are normally not allowed, but the award was left unchanged since the judges were not aware of Steinman's death when they selected him as a winner.

Sunday, November 13, 2011

Pope makes it clear: no to embryonic stem cells

Religion - WORLD

Pope: Yes to Adult Stem Cells, No Embryonic

Published November 12, 2011
| Associated Press


VATICAN CITY -- Pope Benedict XVI has reaffirmed his opposition to embryonic stem cell research, saying it's morally wrong to destroy an embryo no matter how beneficial the resulting treatment is.
Benedict made the comments Saturday to participants of a Vatican conference on adult stem cells convened under an unusual new partnership between the Vatican's culture office and a small U.S. biotech firm, NeoStem Inc.
Church teaching holds that life begins at conception. As a result, the Vatican opposes embryonic stem cell research because embryos are destroyed in the process. It supports research using adult stem cells.
Benedict said: "The destruction of even one human life can never be justified in terms of the benefit that it might conceivably bring to another."


Read more: http://www.foxnews.com/world/2011/11/12/pope-yes-to-adult-stem-cells-no-embryonic/#ixzz1dabU20GV

Monday, March 9, 2009

Could Obama be the most pro-death President?

Our Archbishop has responded to President Obama's executive order today. This after several policy reversals already aimed at promoting the culture of death. We must continue to pray for a change of heart of all political leaders who are blinded to God's will. Be strong, promote life and pray for the conversion of those who promote death:

From Most Reverend Alfred C. Hughes, Archbishop of New OrleansMarch 9, 2009It is with great disappointment that we learn of President Obama's executiveorder that will now allow federal funding to go towards embryonic stem cell research. It is especially discouraging that this action has been taken at this time since research using adult and umbilical cord stem cells has proven more effective in providing advancements and medical treatments and cures. Moreover, a new procedure called reprogramming makes pluripotent stem cells available without the destruction of human embryos.The Catholic Church is clear in its position that life in all its forms is sacred and deserving of respect. Embryonic stem cell research calls for thedestruction of human embryos, which is blatantly anti-life. The Catholic Church favors stem cell research using adult stem cells, stem cells from umbilical cord blood, or stem cells procured through reprogramming, research that not only respects life but has been shown to be life-giving and life-saving. When a life-affirming alternative is available, it is unfortunate that the federal government should allow tax payer dollars to gotowards research that is void of respect for life and objectionable to tax payers themselves.###For more information contact the Archdiocese of New Orleans Respect Life Office at (504) 834-5433.Sarah ComiskeyOffice of CommunicationsArchdiocese of New Orleans(504) 596-3023scomiskey@archdiocese-no.org